Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
CALT Calliditas Therapeutics
- 40.000
- 0.0000.00%
Close Sep 20 16:00 ET
1.08BMarket Cap-23.89P/E (TTM)
0.000High0.000Low0Volume40.000Open40.000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)27.02MShares43.00052wk High108.11P/B13.54MFloat Cap16.00052wk Low--Dividend TTM338.45KShs Float43.000Historical High--Div YieldTTM0.00%Amplitude10.820Historical Low--Avg Price1Lot Size
About Calliditas Therapeutics Company
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.
Company Profile
SymbolCALT
Company NameCalliditas Therapeutics
Issue Price19.50
CEOMs. Renee Aguiar-Lucander
MarketNASDAQ
Employees195
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
Company Executives
- Name
- Position
- Salary
- Renee Aguiar-Lucander
- Chief Executive Officer
- --
- Dr. Richard Philipson, M.D.
- Chief Medical Officer
- --
- Fredrik Johansson
- Chief Financial Officer
- --
- Dr. Frank Bringstrup, M.D.
- Vice President, Regulatory Affairs
- --
- Elmar Schnee
- Chairman of the Board
- --
- Monika Maria Tornsen
- President, North America
- --
- Henrik Stenqvist
- Independent Director
- --
- Frederick W. Driscoll
- Independent Director
- --
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- --
- Diane L. Parks, M.B.A.
- Independent Director
- --
- Hilde Furberg
- Independent Director
- --
- Brian Gorman
- Group General Counsel
- --
- Lars Stubberud
- Head of Technical Operations
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.